Characteristics and Related Factors of Chinese Herbal Medicine Use in Middle-Aged and Older Patients with Cardiovascular Disease in China: A Cross-Sectional Study.

IF 2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Patient preference and adherence Pub Date : 2025-08-25 eCollection Date: 2025-01-01 DOI:10.2147/PPA.S538773
Long Chen, Yu-Li Huang, Fang Liu, Nan Huang, Ding-Cheng Zeng, Yan-Biao Zhong, Jing-Hai Liao, Mao-Yuan Wang
{"title":"Characteristics and Related Factors of Chinese Herbal Medicine Use in Middle-Aged and Older Patients with Cardiovascular Disease in China: A Cross-Sectional Study.","authors":"Long Chen, Yu-Li Huang, Fang Liu, Nan Huang, Ding-Cheng Zeng, Yan-Biao Zhong, Jing-Hai Liao, Mao-Yuan Wang","doi":"10.2147/PPA.S538773","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) poses a significant health burden in middle-aged and older Chinese populations, with Chinese herbal medicine (CHM) often used as a complementary therapy. This study aimed to analyze the characteristics of CHM use and its influencing factors in middle-aged and older Chinese patients with CVD.</p><p><strong>Methods: </strong>This was a cross-sectional study based on data from the 2018 China Health and Aging Longitudinal Study (CHARLS). We surveyed 4511 patients with CVD, aged 45 years or older, who reported using CHM to analyze their demographic characteristics, healthcare utilization, and health status.</p><p><strong>Results: </strong>Approximately 24.05% (1085/4511) of the participants reported managing CVD with CHM. Compared with non-users, CHM users were older (OR=1.21; 95% CI=1.04-1.40), more educated (OR=1.30; 95% CI=1.08-1.57), more likely to reside in a city (OR=1.19; 95% CI=1.01-1.41), and were associated with visiting a Chinese medicine hospital (OR=1.17; 95% CI=1.01-1.37), self-medication (OR=1.48; 95% CI=1.24-1.77), poor health (OR=1.52; 95% CI=1.17-1.98), comorbidities such as kidney disease (OR=1.34; 95% CI=1.02-1.75), asthma (OR=1.67; 95% CI=1.21-2.32), and emotional problems (OR=1.98; 95% CI=1.28-3.07). In an additional interaction analysis, patients with urban residence and mood problems were most likely to use CHM (OR=6.93, 95% CI: 1.77-27.19).</p><p><strong>Conclusion: </strong>Factors contributing to CHM use in middle-aged and older patients with CVD are multifaceted, encompassing demographic characteristics, health service, and health status.</p>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"19 ","pages":"2623-2633"},"PeriodicalIF":2.0000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient preference and adherence","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PPA.S538773","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiovascular disease (CVD) poses a significant health burden in middle-aged and older Chinese populations, with Chinese herbal medicine (CHM) often used as a complementary therapy. This study aimed to analyze the characteristics of CHM use and its influencing factors in middle-aged and older Chinese patients with CVD.

Methods: This was a cross-sectional study based on data from the 2018 China Health and Aging Longitudinal Study (CHARLS). We surveyed 4511 patients with CVD, aged 45 years or older, who reported using CHM to analyze their demographic characteristics, healthcare utilization, and health status.

Results: Approximately 24.05% (1085/4511) of the participants reported managing CVD with CHM. Compared with non-users, CHM users were older (OR=1.21; 95% CI=1.04-1.40), more educated (OR=1.30; 95% CI=1.08-1.57), more likely to reside in a city (OR=1.19; 95% CI=1.01-1.41), and were associated with visiting a Chinese medicine hospital (OR=1.17; 95% CI=1.01-1.37), self-medication (OR=1.48; 95% CI=1.24-1.77), poor health (OR=1.52; 95% CI=1.17-1.98), comorbidities such as kidney disease (OR=1.34; 95% CI=1.02-1.75), asthma (OR=1.67; 95% CI=1.21-2.32), and emotional problems (OR=1.98; 95% CI=1.28-3.07). In an additional interaction analysis, patients with urban residence and mood problems were most likely to use CHM (OR=6.93, 95% CI: 1.77-27.19).

Conclusion: Factors contributing to CHM use in middle-aged and older patients with CVD are multifaceted, encompassing demographic characteristics, health service, and health status.

Abstract Image

中国中老年心血管疾病患者中草药使用特点及相关因素:一项横断面研究
背景:心血管疾病(CVD)在中国中老年人群中构成了巨大的健康负担,中草药(CHM)常被用作辅助治疗。本研究旨在分析中国中老年CVD患者中草药的使用特点及其影响因素。方法:基于2018年中国健康与老龄化纵向研究(CHARLS)的数据进行横断面研究。我们调查了4511名年龄在45岁或以上的CVD患者,他们报告使用CHM来分析他们的人口统计学特征、医疗保健利用和健康状况。结果:大约24.05%(1085/4511)的参与者报告CVD合并CHM得到了控制。相比,CHM用户老(OR = 1.21; 95%可信区间-1.40 = 1.04),受教育程度更高(OR = 1.30; 95%可信区间-1.57 = 1.08),更有可能驻留在一个城市(OR = 1.19; 95%可信区间-1.41 = 1.01),并与来访的有关中医医院(OR = 1.17; 95%可信区间-1.37 = 1.01),自我药疗(OR = 1.48; 95%可信区间-1.77 = 1.24),健康状况不佳(OR = 1.52; 95%可信区间-1.98 = 1.17),并发症如肾脏疾病(OR = 1.34; 95%可信区间-1.75 = 1.02),哮喘(OR = 1.67; 95%置信区间CI = 1.21 - -2.32),和情绪问题(OR = 1.98;95% CI = 1.28 - -3.07)。在另一项相互作用分析中,居住在城市且有情绪问题的患者最有可能使用CHM (OR=6.93, 95% CI: 1.77-27.19)。结论:影响中老年CVD患者使用CHM的因素是多方面的,包括人口特征、卫生服务和健康状况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Patient preference and adherence
Patient preference and adherence MEDICINE, GENERAL & INTERNAL-
CiteScore
3.60
自引率
4.50%
发文量
354
审稿时长
6-12 weeks
期刊介绍: Patient Preference and Adherence is an international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal. As of 1st April 2019, Patient Preference and Adherence will no longer consider meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信